Marathon Asset Management LLP reduced its stake in shares of Genpact Limited (NYSE:G) by 2.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,247,180 shares of the business services provider’s stock after selling 37,708 shares during the quarter. Marathon Asset Management LLP owned 0.66% of Genpact worth $38,176,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Intrust Bank NA grew its holdings in shares of Genpact by 9.4% during the second quarter. Intrust Bank NA now owns 24,423 shares of the business services provider’s stock worth $707,000 after purchasing an additional 2,102 shares during the last quarter. Strs Ohio grew its holdings in shares of Genpact by 14.4% during the third quarter. Strs Ohio now owns 16,701 shares of the business services provider’s stock worth $511,000 after purchasing an additional 2,107 shares during the last quarter. OLD National Bancorp IN grew its holdings in shares of Genpact by 5.4% during the second quarter. OLD National Bancorp IN now owns 41,317 shares of the business services provider’s stock worth $1,195,000 after purchasing an additional 2,116 shares during the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Genpact by 15.3% during the second quarter. State of Alaska Department of Revenue now owns 16,120 shares of the business services provider’s stock worth $465,000 after purchasing an additional 2,140 shares during the last quarter. Finally, SRS Capital Advisors Inc. grew its holdings in shares of Genpact by 88.6% during the second quarter. SRS Capital Advisors Inc. now owns 4,820 shares of the business services provider’s stock worth $139,000 after purchasing an additional 2,264 shares during the last quarter. Hedge funds and other institutional investors own 88.59% of the company’s stock.
Genpact stock opened at $27.34 on Tuesday. The stock has a market capitalization of $5.20 billion, a P/E ratio of 18.35, a PEG ratio of 1.75 and a beta of 0.64. Genpact Limited has a 12-month low of $26.46 and a 12-month high of $34.79. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 0.76.
Genpact (NYSE:G) last issued its earnings results on Tuesday, August 7th. The business services provider reported $0.41 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.40 by $0.01. Genpact had a return on equity of 22.15% and a net margin of 9.44%. The firm had revenue of $728.56 million for the quarter, compared to analysts’ expectations of $734.51 million. As a group, equities analysts predict that Genpact Limited will post 1.56 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Monday, December 10th will be issued a dividend of $0.075 per share. This represents a $0.30 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date is Friday, December 7th. Genpact’s dividend payout ratio (DPR) is currently 20.13%.
In other Genpact news, Director Carol Lindstrom sold 2,630 shares of the firm’s stock in a transaction dated Friday, August 17th. The stock was sold at an average price of $30.44, for a total transaction of $80,057.20. Following the transaction, the director now owns 17,141 shares in the company, valued at $521,772.04. The sale was disclosed in a document filed with the SEC, which is available through this link. 1.88% of the stock is currently owned by company insiders.
Several research firms recently issued reports on G. Cantor Fitzgerald reiterated a “buy” rating and issued a $36.00 price target on shares of Genpact in a report on Wednesday, August 8th. JPMorgan Chase & Co. decreased their price target on Genpact from $33.00 to $32.00 and set an “underweight” rating on the stock in a report on Wednesday, October 24th. Zacks Investment Research cut Genpact from a “hold” rating to a “sell” rating in a report on Tuesday, October 9th. Finally, SunTrust Banks reiterated a “buy” rating and issued a $37.00 price target on shares of Genpact in a report on Thursday, August 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $35.79.
TRADEMARK VIOLATION NOTICE: This news story was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/11/06/genpact-limited-g-holdings-cut-by-marathon-asset-management-llp.html.
Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; over-the counter services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.
Read More: How analysts view the yield curve
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.